Europe Hypodermic Needles Market

Market Introduction

The safety needles market is anticipated to grow in the forecast period owing to driving factors such as high prevalence of blood-borne disease, active government participation to implement stringent regulations, increase in demand for injectable drugs & vaccines and untapped potential in the emerging economies. Nevertheless, high cost of safety needles and alternative drug delivery options are expected to hamper the market growth during the forecast period.

Moreover, the surge in demand for vaccines is expected to bolster the market growth during the forecast period.

The COVID-19 Pandemic has necessitated rapid vaccine development for the control of the disease. Most vaccinations, including those currently approved for COVID-19, are administered intramuscularly and subcutaneously using hypodermic needles. Similarly, In March 2021, Catalent Expanded its Partnership with Johnson & Johnson to Significantly Increase Capacity for Sterile Manufacturing and Packaging of COVID-19 Vaccine in Italy. Catalent announced Catalent Biologics would significantly increase the manufacturing capacity for large-scale commercial supply of Janssen’s COVID-19 vaccine at Catalent’s manufacturing facility in Anagni, Italy. Thus, the Europe hypodermic needles market is positively impacted due to COVID-19.

Market Overview and Dynamics

The Europe hypodermic needles market is expected to reach US$ 1502.9 million by 2028 from US$ 985.8 million in 2021. The market is estimated to grow at a CAGR of 6.2% from 2021–2028. Manufacturers in the hypodermic needles market are raising the availability of precision-engineered needles and needlestick prevention technologies to excel in challenging applications. Companies are providing safe designs and less painful injections to ensure therapeutic success. Hypodermic needles are undergoing controlled manufacturing and robust inspection for quality assurance to face the competition placed by needle-free injectors. For instance, in April 2021, Misawa Medical Industry Co., Ltd. launched "low dead space needles" to reduce the amount of medicinal liquid remaining inside the syringe. This decreases the dead space, in which the liquid remains in the syringe without using a special syringe, reducing the therapeutic drug's wastage.

Key Market Segments

In terms of type, the safety needles segment accounted for the largest share of the Europe hypodermic needles market in 2020. In terms of application, the drug delivery segment accounted for the largest share of the Europe hypodermic needles market in 2020. In terms of end user, the hospital segment accounted for the largest share of the Europe hypodermic needles market in 2020. Further, based on usage, the disposable segment held the largest market share in 2020.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the hypodermic needles market in Europe are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Terumo Corporation, BD, B. Braun Melsungen AG, Catalent Inc., Cardinal Health Inc., Vygon, and Barber of Sheffield.

Reasons to Buy Report

• To understand the Europe hypodermic needles market landscape and identify market segments that are likely to guarantee a strong return
• To comprehend the ever-changing market landscape and stay ahead in competition
• To efficiently plan merger and acquisition, and partnership deals in the Europe hypodermic needles market by identifying segments with the most promising probable sales
• To make knowledgeable business decisions from perceptive and comprehensive analysis of the market performance of various segments
• To obtain market revenue forecast of the Europe hypodermic needles market based on various segments for the period 2021–2028

EUROPE HYPODERMIC NEEDLES MARKET SEGMENTATION

By Type

• Safety Needles
  • Retractable Needles
  • Non-retractable Needles
• Non-safety Needles

By Application

• Drug Delivery
• Vaccination
• Blood Specimen Collection

By End User

• Hospitals and Clinics
• Diagnostic Centers
• Home Health Care

By Usage

• Disposable
• Reusable

By Country

• Europe
  • •    Germany
  • •    UK
  • •    France
  • •    Spain
  • •    Italy
  • •    Rest of Europe

     

Companies Mentioned

• Terumo Corporation
• BD
• B. Braun Melsungen AG
• Catalent Inc
• Cardinal Health Inc
• Vygon
• Barber of Sheffield

Europe Hypodermic Needles Strategic Insights

Strategic insights for the Europe Hypodermic Needles provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Europe Hypodermic Needles Report Scope

Europe Hypodermic Needles Regional Insights

The geographic scope of the Europe Hypodermic Needles refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.